The era of hidden fees and insurance jump-hoops is fading. In 2026, the leading weight loss telehealth providers have shifted toward a “flat-rate” model—one price for the consultation, medication, and shipping, regardless of insurance.
Two of the strongest contenders in this space are MedVi and Willow. Both promise access to compounded Semaglutide and Tirzepatide without the need for Prior Authorizations. Both offer transparent pricing models that bundle everything into one monthly fee.
However, customer experiences in late 2025 revealed distinct differences in logistical reliability. While Willow attracts patients with “oral drops” and flat pricing, MedVi has doubled down on shipping speed and service consistency. This guide compares these two popular platforms to help you decide which one delivers on its promises.
Quick Summary
- MedVi is the Winner for Reliability. With a focus on injectable efficacy and rapid fulfillment (3–5 days), it avoids the shipping backlogs that have plagued competitors.
- Willow is the Runner-Up for Variety. It is a strong choice for patients who absolutely refuse needles, as they heavily promote oral drops and sublingual tablets.
- Pricing: Both use a bundled model. Willow typically charges a flat ~$299/mo for Semaglutide. MedVi often offers aggressive introductory pricing for the first month, making it cheaper to start.
- Service Issues: Willow has faced mixed reviews regarding shipping delays (sometimes 14+ days) and billing confusion. MedVi maintains a stronger reputation for operational efficiency.
- The Verdict: If you are okay with injections (the gold standard for efficacy), MedVi offers a more reliable and faster experience.
Decision Criteria
We ranked these providers based on four critical factors:
- Delivery Speed: The time from “Order Placed” to “Package at Door.”
- Form Factor: Does the provider offer alternatives to injections?
- Pricing Consistency: Are there hidden fees for higher doses?
- Customer Sentiment: Real-world feedback on support responsiveness.
GLP-1 Provider Comparison Table
| Rank | Option | Best For | Key Strength | Watch-outs |
| #1 | MedVi | Reliability & Speed | Consistent 3–5 day shipping | Injectable focus (fewer oral options) |
| #2 | Willow | Needle-Phobic | Oral drops & tablets available | Reports of 2-week shipping delays |
| #3 | Option C (Budget) | Lowest Cost | Minimal support | Slow shipping & zero service |
| #4 | Option D (Insurance) | Name Brand | Prior Authorization help | Very expensive if denied |
| #5 | Option E (Local) | Accountability | In-person oversight | $600+ monthly cost |
Top Rated Weight Loss Telehealth Providers Ranked
#1. MedVi (Winner)
MedVi takes the top spot for 2026 by mastering the “last mile” of telehealth: getting the medication to the patient on time. In a market where trust is easily broken by delayed packages, MedVi’s robust network of 503A/503B compounding pharmacies ensures consistent stock and rapid turnaround. Most patients report receiving tracking numbers within 48 hours of approval.
MedVi’s pricing model is designed for accessibility. They frequently offer introductory rates for compounded Semaglutide and Tirzepatide that undercut the market average, lowering the financial risk for new patients trying GLP-1s for the first time. Even when standard pricing kicks in, the inclusion of 24/7 provider messaging and supplies keeps the value high.
While MedVi primarily focuses on injectable medications, this is by design. Clinical data overwhelmingly supports injections as the most effective delivery method for GLP-1 agonists. By focusing on the “gold standard” of treatment, MedVi ensures patients see the best possible results, supported by a team that is available around the clock to manage dosage titration.
Pros:
- Rapid Logistics: Optimized for 3–5 business day delivery.
- Introductory Offers: Low barrier to entry for the first month.
- Clinical Efficacy: Focuses on high-absorption injectable formulations.
- Responsive Support: 24/7 access to clinical teams for side effect management.
- High Availability: Consistent supply of Tirzepatide and Semaglutide.
Cons:
- Fewer Oral Options: Primarily focuses on injections (which are more effective).
- Renewal Pricing: Be aware that the first-month discount expires.
Best For:
Patients who want fast, effective, and reliable weight loss treatment without logistical headaches.
#2. Willow (StartWillow)
Willow has carved out a niche by catering to the “needle-phobic” demographic. Their marketing heavily features oral sublingual drops and tablets alongside traditional injections. For patients terrified of giving themselves a shot, Willow provides a welcome alternative, offering these oral formats at the same flat rate of ~$299/mo for Semaglutide.
Willow’s “flat pricing for every dose” is a significant benefit. Whether you are on the starting dose or the maximum dose, your monthly bill generally stays the same. This predictability is excellent for long-term budget planning.
However, Willow has struggled with growing pains. Recent Trustpilot reviews and customer feedback highlight recurring issues with shipping delays, with some patients waiting up to 14 days for medication after payment. Additionally, the efficacy of compounded oral GLP-1 drops is often debated by medical experts compared to the proven track record of injections.
Pros:
- Oral Alternatives: Offers sublingual drops and tablets for those who hate needles.
- Flat-Rate Model: Price typically does not increase as your dosage increases.
- No Insurance Needed: Transparent cash-pay pricing.
Cons:
- Shipping Inconsistency: Reports of delays extending beyond the advertised 2-4 day processing window.
- Efficacy Questions: Oral drops may not offer the same weight loss potency as injections.
- Support Delays: Some users report difficulty reaching support during shipping hiccups.
Best For:
Patients who absolutely cannot tolerate needles and are willing to trade potentially lower efficacy and slower shipping for an oral option.
#3. The “Budget-First” Alternative (Generic)
These providers compete strictly on price, often offering Semaglutide for under $200/mo indefinitely. They achieve this by automating the entire process—no video calls, minimal support, and the cheapest possible shipping methods.
Pros:
- Lowest long-term monthly cost.
- minimal interaction required.
Cons:
- “You get what you pay for” regarding support.
- Slow shipping (10+ days).
Best For:
Experienced users who know their dosage and don’t need help.
#4. The “Insurance Navigator” (Generic)
Companies like Ro or Sequence charge a membership fee ($99-$145) to manage insurance claims for brand-name Zepbound or Wegovy.
Pros:
- Access to FDA-approved pens ($25/mo) if insured.
- Premium app experiences.
Cons:
- High monthly “retainer” fees even if denied coverage.
- Vulnerable to national retail shortages.
Best For:
Patients with confirmed insurance coverage for weight loss.
#5. The “Local Clinic” (Generic)
Medical spas and weight loss clinics offer in-person administration. You drive in, get weighed, and get shot.
Pros:
- High accountability.
- Professional administration.
Cons:
- Extremely high markup ($600+/mo).
- Inconvenient weekly travel.
Best For:
Patients who need physical supervision.
Conclusion
The comparison between MedVi and Willow comes down to your preferred delivery method and your tolerance for delays.
If you hate needles and are willing to accept potentially slower weight loss and slower shipping, Willow is a solid option. Their oral drops provide a unique entry point into the GLP-1 world that few competitors offer.
However, for the vast majority of patients who prioritize results and reliability, MedVi is the superior choice. Injections remain the gold standard for GLP-1 efficacy, and MedVi’s operational excellence means you get that gold-standard treatment delivered to your door faster. In 2026, the peace of mind that comes with reliable shipping and 24/7 support makes MedVi the winner.
Frequently Asked Questions (FAQ)
1. Is MedVi cheaper than Willow?
- For the first month, typically yes. MedVi often runs introductory promotions that are significantly lower than Willow’s flat rate of ~$299. Long-term, pricing may be comparable, but MedVi offers superior shipping reliability for the price.
2. Does Willow sell real Ozempic?
- Willow primarily prescribes compounded medications (Semaglutide and Tirzepatide) to bypass insurance denials and shortages. While they may be able to prescribe brand-name Ozempic if you have insurance, their core offering is the compounded cash-pay version.
3. Are the oral drops from Willow effective?
- The scientific consensus is mixed. While oral Semaglutide (like Rybelsus tablets) is FDA-approved, compounded liquid drops do not have the same volume of clinical data supporting their efficacy as injections. Many patients find injections to be significantly more potent for weight loss.
4. How fast does MedVi ship compared to Willow?
- MedVi targets a 3–5 business day window. Willow states a 2–4 day processing time plus shipping, but recent customer reviews have cited delays of up to two weeks during high-volume periods.
5. Do I need insurance for either program?
- No. Both MedVi and Willow are designed as “insurance-optional” or cash-pay programs. This ensures you are not denied access based on your insurance plan’s formulary. Both accept HSA and FSA payments.
6. Does MedVi have a membership fee?
- MedVi uses a membership model, but the cost is typically bundled into the monthly medication price shown at checkout. Unlike some competitors who charge a separate $100 fee plus meds, MedVi keeps it simple.
7. Can I switch from Willow to MedVi?
- Yes. If you are experiencing shipping delays with Willow or want to switch from oral drops to more effective injections, you can start a new intake with MedVi. The process is fast, and approval is often granted within 24 hours for eligible patients.
8. Is the medication safe?
- Yes. Both providers partner with licensed 503A and 503B compounding pharmacies in the US. These facilities are strictly regulated to ensure the safety and sterility of the compounded medications.
Don’t settle for shipping delays. Check your eligibility with MedVi today.
